NSC |
Compound |
Enrichment |
Correlation |
NSC 705871 |
1H-Indole, 5-bromo-3-[2-(2-pyridinyl)-4-thiazolyl]- |
0.00396536695012846 |
0.29591993 |
NSC 724910 |
3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin, 10,10'-[(2-hydroxy-1,3-propanediyl)bis(oxy)] bis[decahydro- 3,6,9-trimethyl-, hemisuccinate |
0.00396536695012846 |
0.38881867 |
NSC 727985 |
NSC 708781 incorporated in micelles, 0.55% (w/w) of drug |
0.00396536695012846 |
0.24333281 |
NSC 728512 |
1-Allyl-2-[4-chloro-5-(4-chlorophenylcarbamoyl)-2-methylthio benzenesulfonyl]-3-(5-nitro-2-furfulienimino)guanidine |
0.00396536695012846 |
0.29777191 |
NSC 752385 |
Null |
0.00456325077253396 |
0.095965748 |
NSC 637009 |
Null |
0.00526022686151165 |
0.30118308 |
NSC 676779 |
Olean-12-en-28-oic acid, 3-.beta.-[3-O-(.beta.-L-arabinopyranosyl)- 6-methyl-.beta.-D-glucopyranuronosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-(.beta.-D-xylop |
0.00526022686151165 |
0.23437296 |
NSC 677672 |
Null |
0.00526022686151165 |
0.37420418 |
NSC 690270 |
ANTINEOPLASTIC-690270 |
0.00526022686151165 |
0.32257424 |
NSC 736065 |
2-(4-Trifluoromethoxy-benzenesulfonylimino)-imidazolidine-1- carbodithioic acid 3-thioxo-5,6-dihydro-imidazo[2,1-c][1,2,4]thiadiazol-7-yl ester |
0.00526022686151168 |
0.32627236 |